These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6578657)

  • 1. Etiology and pathogenesis of monophasic and relapsing inflammatory demyelination - human and experimental.
    Wisniewski HM; Lassmann H
    Acta Neuropathol Suppl; 1983; 9():21-9. PubMed ID: 6578657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis.
    Lassmann H
    J Neurol; 1983; 229(4):207-20. PubMed ID: 6192222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis.
    Lassmann H; Wisniewski HM
    Arch Neurol; 1979 Aug; 36(8):490-7. PubMed ID: 508161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H
    Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions.
    Traugott U
    Springer Semin Immunopathol; 1985; 8(1-2):71-95. PubMed ID: 3890238
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental models of multiple sclerosis.
    Lassmann H
    Rev Neurol (Paris); 2007 Jun; 163(6-7):651-5. PubMed ID: 17607184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 8. [Demyelination and autoimmunity].
    Lebar R
    Pathol Biol (Paris); 1987 Mar; 35(3):275-83. PubMed ID: 3295694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental Models of Autoimmune Demyelinating Diseases in Nonhuman Primates.
    Stimmer L; Fovet CM; Serguera C
    Vet Pathol; 2018 Jan; 55(1):27-41. PubMed ID: 28583039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice.
    Sher F; Amor S; Gerritsen W; Baker D; Jackson SL; Boddeke E; Copray S
    Cell Transplant; 2012; 21(9):1883-97. PubMed ID: 22469520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restricted immune responses lead to CNS demyelination and axonal damage.
    Mancardi G; Hart BA; Capello E; Brok HP; Ben-Nun A; Roccatagliata L; Giunti D; Gazzola P; Dono M; Kerlero de Rosbo N; Colombo M; Uccelli A
    J Neuroimmunol; 2000 Jul; 107(2):178-83. PubMed ID: 10854654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel monoclonal antibodies against proteolipid protein peptide 139-151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesions.
    Laman JD; Visser L; Maassen CB; de Groot CJ; de Jong LA; 't Hart BA; van Meurs M; Schellekens MM
    J Neuroimmunol; 2001 Sep; 119(1):124-30. PubMed ID: 11525809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.
    Elieh-Ali-Komi D; Cao Y
    Clin Rev Allergy Immunol; 2017 Jun; 52(3):436-445. PubMed ID: 28025778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New immunopathologic insights into multiple sclerosis.
    Hemmer B; Kieseier B; Cepok S; Hartung HP
    Curr Neurol Neurosci Rep; 2003 May; 3(3):246-55. PubMed ID: 12691630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between cell-mediated demyelination and astrocyte stimulation.
    Smith ME; Sommer MA
    Prog Brain Res; 1992; 94():411-22. PubMed ID: 1287726
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple sclerosis animal models: a clinical and histopathological perspective.
    Kipp M; Nyamoya S; Hochstrasser T; Amor S
    Brain Pathol; 2017 Mar; 27(2):123-137. PubMed ID: 27792289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.